Plasmic hemostasis and some biochemical indices in trimetasidine treatment in patients with chronic heart failure

Terapevticheskii Arkhiv

Volumn 70, Issue 6, 1998, Pages 41-44

  Tereschenko, S N ^a   Drozdov, V N ^a   Levchuk, N N ^a   Demidova, I V ^a  

^a NONE

Author keywords

Blood biochemistry; Chronic cardiac failure; Hemostasis; Treatment; Trimetazidine

Indexed keywords

ACID PHOSPHATASE; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TRIMETAZIDINE; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC DISEASE; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; FOLLOW UP; HEMOSTASIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PLASMA; TREATMENT OUTCOME;

ACID PHOSPHATASE; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; CHOLESTEROL, HDL; CHRONIC DISEASE; CREATININE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PLASMA; TREATMENT OUTCOME; TRIGLYCERIDES; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 2542420399     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Belcher P., Drake-Holland A. J., Nabele M. I. M. // Cardiovase. Drugs Ther. - 1993. - Vol. 77. - P. 149-157.
2. Demaison L, Fantini E., Sentex E. et al. // Amer. J. Cardiol - 1995. - Vol. 76. - P. 31B-37B.
3. Fantini F., Demaison L., Sentex E. et al. // J. Mol. Cell. Cardiol. - 1994. - Vol. 26. - P. 949-958.
4. Ferrari R. // European Society of Cardiology Congress, 18-th. - Birmingham, 1996. - P. 448.
5. Fuyno Y. // Kurumee Ig Zar - 1996. - Vol. 29. - P. 181-198.
6. Guarnieri C., Muscari C. // Cardiovasc. Drugs. - 1990. Vol. 4, Suppl. 4. - P. 814-815.
7. Higuchi H., Hayashi M., Sano I. et al. // J. Nissei. Hospital. 1981. - Vol. 9. - P. 89-95.
8. Jackson P, I., Brawnsill R. D., Taylor A. R. // Xenobiotica. 1996 - Vol. 26, No 2. - P. 221-228.
9. Johannessen K. A., Nordrehaug J. E., Von der Lippe G. // Brit. Heart J. - 1984. - Vol. 51 - P. 553-556.
10. Jordan R. A., Miller R. D., Edvards J. E., Parker R. L. // Circulation. - 1952. - Vol. 6. - P. 1-6.
11. Jugdutt B. I., Sivaram C. A. // J. Amer. Coll. Cardiol. - 1989. - Vol. 13. - P. 554-564.
12. Kleber F. K., Wensel R. // Drugs - 1996. - Vol. 51, Suppl. 1. - P. 89-98.
13. Oulsman I., Taylor A. R., Ings B., Campbell B. // Gaz. Med. Fr. - 1984. - Vol. 91, Suppl. 26. - P. 71-77.
14. Pfeffer M. A., Brunvald E., Moye L. A. // N. Engl, J. Med. 1992. - Vol. 327. - P. 669-677.
15. Pornin M., Harpey C., Allan J. et al. // Clin. Trials Meta-Anal. - 1994. - Vol 29. - P. 49-56
16. Rossi A., Lavanchy N., Martin J. // Cardiovasc. Drugs. 1990. - Vol. 4, Suppl. 4. - P. 812-813.
17. Shirahase H., Suzuki Y., Osumi S. et al. // Jap. J. Pharmacol. - 1988. - Vol. 47. - P 29-34.
18. Schulte B. P. M., Van Gijn J. // Epidemiologie van zeiktenin Nederland / Eds. D. E. Grobbee, F. Hofman. - Utrecht: 1989 - P. 223-228.
19. The SOLVD investigators: Effect of enalapril on survival in patients with reduced left ventriculare ejection fraction and congestive heart failure // N. Engl J. Med. - 1991 - Vol. 325. - P. 293-302.